(1) These Regulations have effect as if a written assurance given before 1 January 2020 under paragraph 12AB(2)(a) that clinical trials would be conducted in accordance with the Practice Guidelines were, on and after 1 January 2020, a written assurance that clinical trials would be conducted in accordance with the Practice Guideline.
(2) The amendment of subregulation 12AC(1) made by Part 2 of Schedule 9 to the amending regulations applies in relation to things done on or after 1 January 2020 in relation to a clinical trial that began before, on or after 1 January 2020.
(3) The amendment of paragraph 12AD(a) made by Part 2 of Schedule 9 to the amending regulations applies in relation to uses on or after 1 January 2020 in relation to a clinical trial that began before, on or after 1 January 2020.
(4) The amendment of Schedule 5A made by Part 2 of Schedule 9 to the amending regulations applies in relation to:
(a) requests made on or after 1 January 2020 to give information acquired before, on or after 1 January 2020; and
(b) things mentioned in regulation 12AC done on or after 1 January 2020;
in relation to a clinical trial that began before, on or after 1 January 2020.